(WEX) Wex - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US96208T1043
Stock: Fleet Payments, Corporate Payments, Benefit
Total Rating 37
Risk 75
Buy Signal -0.41
| Risk 5d forecast | |
|---|---|
| Volatility | 36.1% |
| Relative Tail Risk | -11.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -25.91 |
| Character TTM | |
|---|---|
| Beta | 1.261 |
| Beta Downside | 1.131 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.15% |
| CAGR/Max DD | -0.09 |
EPS (Earnings per Share)
Revenue
Description: WEX Wex March 05, 2026
WEX Inc. operates a global commerce platform with three main segments.
The Mobility segment provides fleet payment solutions and information management, targeting businesses and government agencies with commercial vehicle fleets. This sectors business model often involves recurring revenue streams from transaction processing fees.
The Corporate Payments segment offers payment solutions, including embedded payments and accounts payable automation for various industries like travel and fintech. Business-to-business (B2B) payment solutions are a growing market, driven by the need for efficiency and cost reduction.
The Benefits segment delivers a SaaS platform for consumer-directed healthcare benefits and enrollment solutions. The healthcare benefits administration sector is characterized by complex regulatory environments and a shift towards digital solutions.
WEX Inc. was founded in 1983 and is headquartered in Portland, Maine. For further details on WEXs financial performance and market position, consider exploring its profile on ValueRay.
Headlines to watch out for
- Fuel price volatility impacts fleet payment volume
- Corporate travel spending influences payment solutions demand
- Healthcare benefits administration growth drives SaaS revenue
- Interest rate changes affect payment processing profitability
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 304.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.39 > 1.0 |
| NWC/Revenue: 16.02% < 20% (prev 7.16%; Δ 8.86% < -1%) |
| CFO/TA 0.03 > 3% & CFO 454.3m > Net Income 304.2m |
| Net Debt (3.95b) to EBITDA (947.8m): 4.17 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.0m) vs 12m ago -10.26% < -2% |
| Gross Margin: 57.77% > 18% (prev 0.61%; Δ 5.72k% > 0.5%) |
| Asset Turnover: 19.20% > 50% (prev 19.73%; Δ -0.53% > 0%) |
| Interest Coverage Ratio: 2.75 > 6 (EBITDA TTM 947.8m / Interest Expense TTM 240.6m) |
Altman Z'' 1.23
| A: 0.03 (Total Current Assets 9.71b - Total Current Liabilities 9.29b) / Total Assets 14.40b |
| B: 0.16 (Retained Earnings 2.37b / Total Assets 14.40b) |
| C: 0.05 (EBIT TTM 661.4m / Avg Total Assets 13.86b) |
| D: 0.17 (Book Value of Equity 2.24b / Total Liabilities 13.16b) |
| Altman-Z'' Score: 1.23 = BB |
Beneish M -2.96
| DSRI: 1.10 (Receivables 3.36b/3.01b, Revenue 2.66b/2.63b) |
| GMI: 1.05 (GM 57.77% / 60.52%) |
| AQI: 0.90 (AQ_t 0.31 / AQ_t-1 0.34) |
| SGI: 1.01 (Revenue 2.66b / 2.63b) |
| TATA: -0.01 (NI 304.2m - CFO 454.3m) / TA 14.40b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of WEX shares?
As of March 19, 2026, the stock is trading at USD 152.53 with a total of 430,847 shares traded.
Over the past week, the price has changed by -7.21%, over one month by -6.35%, over three months by -1.04% and over the past year by -4.30%.
Over the past week, the price has changed by -7.21%, over one month by -6.35%, over three months by -1.04% and over the past year by -4.30%.
Is WEX a buy, sell or hold?
Wex has received a consensus analysts rating of 3.31.
Therefor, it is recommend to hold WEX.
- StrongBuy: 2
- Buy: 1
- Hold: 13
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 172.7 | 13.2% |
| Analysts Target Price | 172.7 | 13.2% |
WEX Fundamental Data Overview March 19, 2026
P/E Trailing = 17.5797
P/E Forward = 8.6806
P/S = 1.92
P/B = 4.2393
P/EG = 1.4468
Revenue TTM = 2.66b USD
EBIT TTM = 661.4m USD
EBITDA TTM = 947.8m USD
Long Term Debt = 3.53b USD (from longTermDebt, last quarter)
Short Term Debt = 1.33b USD (from shortTermDebt, last quarter)
Debt = 4.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.95b USD (from netDebt column, last quarter)
Enterprise Value = 9.06b USD (5.11b + Debt 4.86b - CCE 905.8m)
Interest Coverage Ratio = 2.75 (Ebit TTM 661.4m / Interest Expense TTM 240.6m)
EV/FCF = 30.29x (Enterprise Value 9.06b / FCF TTM 299.2m)
FCF Yield = 3.30% (FCF TTM 299.2m / Enterprise Value 9.06b)
FCF Margin = 11.24% (FCF TTM 299.2m / Revenue TTM 2.66b)
Net Margin = 11.43% (Net Income TTM 304.2m / Revenue TTM 2.66b)
Gross Margin = 57.77% ((Revenue TTM 2.66b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 54.44% (prev 60.35%)
Tobins Q-Ratio = 0.63 (Enterprise Value 9.06b / Total Assets 14.40b)
Interest Expense / Debt = 1.21% (Interest Expense 58.8m / Debt 4.86b)
Taxrate = 23.45% (25.8m / 110.0m)
NOPAT = 506.3m (EBIT 661.4m * (1 - 23.45%))
Current Ratio = 1.05 (Total Current Assets 9.71b / Total Current Liabilities 9.29b)
Debt / Equity = 3.94 (Debt 4.86b / totalStockholderEquity, last quarter 1.23b)
Debt / EBITDA = 4.17 (Net Debt 3.95b / EBITDA 947.8m)
Debt / FCF = 13.21 (Net Debt 3.95b / FCF TTM 299.2m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 304.2m / Total Assets 14.40b)
RoE = 29.38% (Net Income TTM 304.2m / Total Stockholder Equity 1.04b)
RoCE = 14.48% (EBIT 661.4m / Capital Employed (Equity 1.04b + L.T.Debt 3.53b))
RoIC = 8.08% (NOPAT 506.3m / Invested Capital 6.26b)
WACC = 5.86% (E(5.11b)/V(9.97b) * Re(10.56%) + D(4.86b)/V(9.97b) * Rd(1.21%) * (1-Tc(0.23)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.60%
[DCF] Terminal Value 86.05% ; FCFF base≈311.1m ; Y1≈302.3m ; Y5≈302.3m
[DCF] Fair Price = 148.5 (EV 9.05b - Net Debt 3.95b = Equity 5.10b / Shares 34.3m; r=5.90% [WACC]; 5y FCF grow -3.93% → 2.90% )
EPS Correlation: 35.89 | EPS CAGR: 9.95% | SUE: 1.64 | # QB: 3
Revenue Correlation: 77.04 | Revenue CAGR: 7.25% | SUE: 1.03 | # QB: 2
EPS next Quarter (2026-06-30): EPS=4.36 | Chg7d=+0.035 | Chg30d=+0.035 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-12-31): EPS=17.62 | Chg7d=+0.083 | Chg30d=+0.083 | Revisions Net=-3 | Growth EPS=+9.4% | Growth Revenue=+3.2%
EPS next Year (2027-12-31): EPS=19.48 | Chg7d=+0.048 | Chg30d=+0.048 | Revisions Net=-5 | Growth EPS=+10.6% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -0.20 (4 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.9% (Discount Rate 10.6% - Earnings Yield 5.7%)
[Growth] Growth Spread = -0.3% (Analyst 4.6% - Implied 4.9%)
P/E Forward = 8.6806
P/S = 1.92
P/B = 4.2393
P/EG = 1.4468
Revenue TTM = 2.66b USD
EBIT TTM = 661.4m USD
EBITDA TTM = 947.8m USD
Long Term Debt = 3.53b USD (from longTermDebt, last quarter)
Short Term Debt = 1.33b USD (from shortTermDebt, last quarter)
Debt = 4.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.95b USD (from netDebt column, last quarter)
Enterprise Value = 9.06b USD (5.11b + Debt 4.86b - CCE 905.8m)
Interest Coverage Ratio = 2.75 (Ebit TTM 661.4m / Interest Expense TTM 240.6m)
EV/FCF = 30.29x (Enterprise Value 9.06b / FCF TTM 299.2m)
FCF Yield = 3.30% (FCF TTM 299.2m / Enterprise Value 9.06b)
FCF Margin = 11.24% (FCF TTM 299.2m / Revenue TTM 2.66b)
Net Margin = 11.43% (Net Income TTM 304.2m / Revenue TTM 2.66b)
Gross Margin = 57.77% ((Revenue TTM 2.66b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 54.44% (prev 60.35%)
Tobins Q-Ratio = 0.63 (Enterprise Value 9.06b / Total Assets 14.40b)
Interest Expense / Debt = 1.21% (Interest Expense 58.8m / Debt 4.86b)
Taxrate = 23.45% (25.8m / 110.0m)
NOPAT = 506.3m (EBIT 661.4m * (1 - 23.45%))
Current Ratio = 1.05 (Total Current Assets 9.71b / Total Current Liabilities 9.29b)
Debt / Equity = 3.94 (Debt 4.86b / totalStockholderEquity, last quarter 1.23b)
Debt / EBITDA = 4.17 (Net Debt 3.95b / EBITDA 947.8m)
Debt / FCF = 13.21 (Net Debt 3.95b / FCF TTM 299.2m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 304.2m / Total Assets 14.40b)
RoE = 29.38% (Net Income TTM 304.2m / Total Stockholder Equity 1.04b)
RoCE = 14.48% (EBIT 661.4m / Capital Employed (Equity 1.04b + L.T.Debt 3.53b))
RoIC = 8.08% (NOPAT 506.3m / Invested Capital 6.26b)
WACC = 5.86% (E(5.11b)/V(9.97b) * Re(10.56%) + D(4.86b)/V(9.97b) * Rd(1.21%) * (1-Tc(0.23)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.60%
[DCF] Terminal Value 86.05% ; FCFF base≈311.1m ; Y1≈302.3m ; Y5≈302.3m
[DCF] Fair Price = 148.5 (EV 9.05b - Net Debt 3.95b = Equity 5.10b / Shares 34.3m; r=5.90% [WACC]; 5y FCF grow -3.93% → 2.90% )
EPS Correlation: 35.89 | EPS CAGR: 9.95% | SUE: 1.64 | # QB: 3
Revenue Correlation: 77.04 | Revenue CAGR: 7.25% | SUE: 1.03 | # QB: 2
EPS next Quarter (2026-06-30): EPS=4.36 | Chg7d=+0.035 | Chg30d=+0.035 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-12-31): EPS=17.62 | Chg7d=+0.083 | Chg30d=+0.083 | Revisions Net=-3 | Growth EPS=+9.4% | Growth Revenue=+3.2%
EPS next Year (2027-12-31): EPS=19.48 | Chg7d=+0.048 | Chg30d=+0.048 | Revisions Net=-5 | Growth EPS=+10.6% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -0.20 (4 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.9% (Discount Rate 10.6% - Earnings Yield 5.7%)
[Growth] Growth Spread = -0.3% (Analyst 4.6% - Implied 4.9%)